Intuitive Surgical (ISRG) Stock Trades At A Discount On Cash Flow But A Premium On Earnings

Intuitive Surgical stock has dropped about 37.1% year to date, yet the current checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to some undervaluation while traditional market multiples suggest the shares screen expensive.

• Year to date, Intuitive Surgical is down 37.1%, which puts recent pricing under pressure even after a 4.7% gain over the last week.
• Expectations around long term procedure growth and new platforms such as da Vinci 5 can support the cash flow outlook. At the same time, rising competition in soft tissue robotics and the spread of unauthorized parts and services may weigh on pricing and margins.
• On Simply Wall St's broader checks, Intuitive Surgical scores 1 out of 6 for value, which leans more toward a rich valuation than a clear bargain.

The issue now is whether the current share price of Intuitive Surgical sits closer to the intrinsic value suggested by the DCF work or to the more cautious picture implied by the earnings multiples.

Find out why Intuitive Surgical's -26.9% return over the last year is lagging behind its peers.

Is Intuitive Surgical Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model looks at the cash Intuitive Surgical can generate in the future and brings it back to today’s value. For Intuitive Surgical, the model uses latest twelve month free cash flow of about $2.7b and assumes that cash flows keep growing rather than shrinking. On that basis, the 2 Stage Free Cash Flow to Equity model points to an intrinsic value of about $406 per share.

That estimated value sits above the current share price, which implies the stock screens around 13.0% undervalued on this framework. The recent pressure from Johnson & Johnson’s Ottava robotic surgery launch helps explain why the market price has fallen below what the DCF output indicates for Intuitive Surgical’s cash generation.

On this DCF view, Intuitive Surgical stock currently looks undervalued relative to its projected cash flows.

Our Discounted Cash Flow (DCF) analysis suggests Intuitive Surgical is undervalued by 13.0%. Track this in your watchlist or portfolio, or discover 55 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Intuitive Surgical.

Has Intuitive Surgical Run Too Far on Earnings?

The P/E ratio suits Intuitive Surgical because earnings remain the main anchor for how the market prices the stock. Right now the stock trades on about 39.8x earnings, which is well above the Medical Equipment industry average of 29.0x and also above the broader peer group at 27.3x.

A more tailored fair P/E for Intuitive Surgical that factors in its size, margins and risk profile sits closer to 34.4x. That is still below the current 39.8x level, which leaves the stock screening as expensive on this framework, even before considering competition from Johnson & Johnson’s Ottava platform and the rising use of unauthorized parts and services.

On the P/E multiple, Intuitive Surgical stock currently screens as overvalued compared with both its customised fair ratio and sector benchmarks.

See what the numbers say about this price — find out in our valuation breakdown.

The Intuitive Surgical Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Intuitive Surgical sit between the DCF output and the P/E signals you just saw. They explain which assumptions about Intuitive Surgical's future growth, margins and earnings would need to hold for the stock to be worth materially more or materially less than today's price. Each narrative links a fair value to a specific mix of potential catalysts and risks, allowing you to track which story is taking shape over time on the Community page.

One of the top community narratives on Intuitive Surgical: 34% undervalued

"ISRG’s robust business model and strong moat come from this recurring revenue, as hospitals must continuously purchase instruments, maintenance services, and software updates to keep their da Vinci systems operational..."

Read one of the top narratives on Intuitive Surgical

Do you think there's more to the story for Intuitive Surgical? Head over to our Community to see what others are saying!

The Bottom Line

For Intuitive Surgical, the Discounted Cash Flow (DCF) work points to some undervaluation on cash generation, while the P/E based view still flags the stock as overvalued relative to peers and a tailored fair ratio. The split mainly reflects different weight on long term cash flows versus current growth expectations and sentiment around competition and pricing pressure. Broader valuation checks remain weak, so the key question is whether procedure growth and new platforms justify today’s richer earnings multiple, or whether competitive and margin risks keep that premium under strain.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com